Eversheds in largest pharmaceutical patent infringement award in Spanish history
Eversheds’ Madrid office has successfully represented pharmaceutical company MSD Spain in a landmark patent dispute, setting a new precedent for patent infringement cases.
The Madrid Commercial Court ordered generic drug companies Chemo Iberica and Quimica Sintetica to pay MSD Spain damages of €20m (£16m) for infringement of the Losartan patent. Losartan is commercially known as the hypertension medication Cozaar.
This ground-breaking decision represents the largest pharmaceutical patent infringement award in Spanish judicial history.
The Eversheds Nicea team, led by partners Kiko Carrión and José Mariano Cruz, acted for MSD Spain.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
Technology acquisitions round-up — Facebook acquires LiveRail; Apple acquires Beats Electronics; and more
In this briefing, Eversheds sets out a choice pick of mergers and acquisitions from 2014 so far.
In Carewatch Care Services v Focus Caring Service and Others, Mr Justice Henderson had to consider the enforceability of standard post-termination restrictions.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe